Publication Name	World Journal of Clinical Urology
Manuscript ID	10984
Country	Japan

Received	2014-04-29 14:25
Peer-Review Started	2014-04-30 13:35
First Decision by Editorial Office Director
Return for Revision	2014-06-19 11:48
Revised	2014-06-26 12:55
Publication Fee Transferred
Second Decision by Editor	2014-07-29 09:00
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-07-29 09:12
Articles in Press	2014-07-29 09:12
Edit the Manuscript by Language Editor	2014-08-07 16:33
Typeset the Manuscript	2014-11-17 08:44
Publish the Manuscript Online	2014-11-19 17:43

ISSN	2219-2816 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Review
Article Title	Review of novel therapeutic medicines targeting androgen signaling in castration-resistant prostate cancer
Manuscript Source	Invited Manuscript
All Author List	Daisuke Obinata, Kyoko Fujiwara, Kenya Yamaguchi, Ken-ichi Takayama, Tomohiko Urano, Hiroki Nagase, Satoshi Inoue, Satoru Takahashi and Noboru Fukuda
Funding Agency and Grant Number
Corresponding Author	Noboru Fukuda, MD, PhD, Division of Life Science, Advanced Research Institute of Sciences and Humanities, Nihon University, 30-1 Ooyaguchikamimachi, Itabashi, Tokyo 173-8610, Japan. fukuda.noboru@nihon-u.ac.jp
Key Words	Androgen receptor; Prostate cancer; Pyrrole-imidazole polyamide
Core Tip	Prostate cancer is the most common male malignant neoplasm. Androgens and the androgen receptor (AR) play a key role in the onset and progression of prostate cancer. The expression of the AR is still preserved in the majority of patients with castration-resistant prostate cancer (CRPC). Therefore, identification of the AR signaling pathways responsible for establishment of CRPC is critical for developing new strategies for the treatment of CRPC.
Publish Date	2014-11-19 17:43
Citation	Obinata D, Fujiwara K, Yamaguchi K, Takayama K, Urano T, Nagase H, Inoue S, Takahashi S, Fukuda N. Review of novel therapeutic medicines targeting androgen signaling in castration-resistant prostate cancer. World J Clin Urol 2014; 3(3): 264-271
URL	http://www.wjgnet.com/2219-2816/full/v3/i3/264.htm
DOI	http://dx.doi.org/10.5410/wjcu.v3.i3.264

Full Article (PDF)	WJCU-3-264.pdf
Full Article (Word)	WJCU-3-264.doc
Manuscript File	10984-Review.docx
Answering Reviewers	10984-Answering reviewers.pdf
Copyright License Agreement	10984-Copyright assignment.pdf
Peer-review Report	10984-Peer review(s).pdf
Scientific Misconduct Check	10984-CrossCheck.jpg
Scientific Editor Work List	10984-Scientific editor work list.pdf